Adalimumab | Etanercept | Infliximab | Total | |
---|---|---|---|---|
Cost per patient/year of biological treatment | ||||
N | 216 | 159 | 132 | 507 |
Mean | 13,073.19€ | 10,172.64€ | 12,283.52€ | 11,957.96€ |
IC95% L_Lower | 12,076.63€ | 9,849.49€ | 11,481.93€ | 11,659.83€ |
IC95% L_Upper | 13,439.75€ | 10,495.79€ | 13,085.10€ | 12,256.08€ |
P_value (biological treatment) | < 0.001 (S) | |||
P_value (ADA vs. ETN) | < 0.001 (S) | |||
P_value (ADA vs. INF) | 0.065 (N. S) | |||
P_value (ETN vs. INF) | < 0.001 (S) |